Surgical Outcome Of da Vinci Single-port Surgical System In Lung Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Early-stage lung cancer represents a clinical challenge that, when diagnosed promptly, offers high chances of cure through lobectomy and lymphadenectomy. In addition to traditional surgery, robotic techniques have become established and have recently evolved further with the Single-Port system, which allows the procedure to be performed through a single subcostal incision rather than multiple openings between the ribs. This approach reduces invasiveness, postoperative pain, and recovery time, while maintaining the same oncological effectiveness and safety as standard techniques. This is a monocentric and non-profit collection of clinical data, both prospective and retrospective, from patients treated with this method, ensuring data privacy through coded information and compliance with current regulations; the study is independent and non-profit.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjenci z potwierdzonym rakiem płuca niedrobnokomórkowym w wczesnym stadium (stopień I)
- •Pacjenci poddani lub planujący operację usunięcia płata płuca wraz z usuniięciem węzłów chłonnych
✗ Disqualifies
- •Brak zgody pacjenta na udział w badaniu
Simplified criteria — AI translation
Trial details
- Last updated (source)
- August 27, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Istituto Europeo di Oncologia
Milan, Italy
Trial contact
Monica Casiraghi, MD PhD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/28/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.